Medtronic gets FDA clearance to advance Mazor platform

Carly Behm -   Print  |

Medtronic received FDA clearance for the use of navigated interbody and Midas Rex high-speed drills with the Mazor Robotic Guidance System, according to a Dec. 16 news release.

The Mazor platform provides surgeons with procedural integration by combining Midas Rex drills with visibility and navigation from the StealthStation software.The clearance came earlier than the company expected, according to the release.

"Transforming spinal care is a top priority for Medtronic and we work closely with customers to develop products that anticipate their needs," Linnea Burman, vice president and general manager of enabling technologies: cranial and spinal technologies at Medtronic, said in the release. "With these recent clearances, we have advanced the Mazor platform by increasing its utility, improving its precision and adding capabilities as we drive toward our goal of delivering value-driven solutions for unmet needs."

Read more here.

More articles on devices:
How CMS' changes will affect spine surgeons in 2021 — Prior authorization, fee cuts & more
Former orthopedic practice owner gets 5 years in prison for illegally prescribing opioids
Surgeons' brand exceeds patient outcomes — How you should build your practice's brand

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers